Generic competition and drug prices in the Malaysian off-patent pharmaceutical market
Omotayo Fatokun, Mohamed Izham Mohamed Ibrahim, Mohamed Azmi Hassali
Pages: 33-37
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
Brian Godman, Biljana Tubic, Eleonora Allocati, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi , Mainul Haque, Sean MacBride-Stewart, Francis Kalemeera, Amos Massele, Iris Hoxha, Vanda Markovic Pekovic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliené, Patricia Vella Bonanno, Jakub Rutkowski, Ileana Mardare , Jurij Fürst, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Farhana Akter, Hye-Young Kwon, Antony P. Martin, Rita Banzi, Janney Wale, Jolanta Gulbinovic
DOI: 10.7324/JAPS.2022.120306Pages: 055–072
Availability, prices, and affordability of essential medicines in Asia: A systematic review
Muhammad Qowiyul Amin, Susi Ari Kristina, Satibi Satibi
DOI: 10.7324/JAPS.2024.183688Pages: 069-076
_.webp)
Towards a drug distributor price reference index: A 2023 survey of pricing discrepancies for region 02 medicines procured from NCR and local distributors, Philippines
Jinky Marie Tuliao Chua, Julius Tamayao Capili, Ma. Angelita Saquing Rabanal, Lily Ann Caldez Mallabo, Jay Emmanuel Laciste Asuncion
DOI: 10.7324/JAPS.2025.v15.i12.5Pages:
